Streptokinase from beta-hemolytic Streptococcus (Lancefield Group C), lyophilized powder, >=3,500 un

Descriptions

Application

Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare. Streptokinase has been used in a study to compare primary coronary intervention and thrombolytic therapy in myocardial infarction patients.

General description

Streptokinase from ?-hemolytic Streptococcus, or Streptokinase from Streptococcus hemolyticus, is effective in thrombolytic therapy.

Packaging

10000, 50000, 250000 units in glass bottle

Physical form

Lyophilized powder containing ~50% total protein by biuret and sodium glutamate. Total protein composed of enzyme protein and human serum albumin.

Unit Definition

One unit is equal to the amount of activity in one unit from a Streptokinase International Standard reference vial.

Specifications

No detailed specifications are available for this product.

Downloads

There are no downloads for this product.

Code	Description	Quality Level	Manufacturer	Storage Temp.	Form	Price	Quantity
3581297	Streptokinase from beta-hemolytic Streptococcus (Lancefield Group C), lyophilized powder, >=3,500 un	200	SIGMA-ALDRICH	−20°C	lyophilized powder	£85.10 (exc VAT) per EACH	- +
3581298	Streptokinase from beta-hemolytic Streptococcus (Lancefield Group C), lyophilized powder, >=3,500 un	200	SIGMA-ALDRICH	−20°C	lyophilized powder	£1,154.68 (exc VAT) per EACH	- +
3581299	Streptokinase from beta-hemolytic Streptococcus (Lancefield Group C), lyophilized powder, >=3,500 un	200	SIGMA-ALDRICH	−20°C	lyophilized powder	£238.18 (exc VAT) per EACH	- +